It’s not the ‘big boy play’ I’ve been talking about for the last month (still sitting on that one), but Emblem Marijuana (SAB.H) has been looming for many months now and is finally jumping into action.
Formerly Kindcann, Emblem is RTOing and currently in the tail end of a raise. They’re valuing it at $22.5 million, which is absurdly cheap compared to the established brands out there, and maybe only a little cheap compared to similarly sized plays.
But where this one comes into its own is with the guys running the show.
Christ on a bike. Not only have you got a 15 year President and CEO of Purdue Pharma in there, you’ve got retail pharmacy knowledge, MMPR knowledge, biotech knowledge, you’ve also got $4.5 million invested personally between them.
I don’t have a deal with Emblem, but with the financing closing (shares are $0.75 with a six month hold), I figured you should know now, rather than later, because it’s a sweet deal.
— Chris Parry